Application of organic bound chrome in disturbed glycoregulation therapy.
Djordjević
P B
PB
Diabetes Center, Institute for Endocrinology, Belgrade, Yugoslavia.
Dimitrijević
V
V
Maksimović
R
R
Vrvić
M
M
Vucetić
J
J
D000596:Amino Acids / Q000627:therapeutic use*; D002857:Chromium / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D007333:Insulin Resistance; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications
D000596:Amino Acids; D009539:Nicotinic Acids; C015240:glucose tolerance factor; D002857:Chromium